BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24157405)

  • 41. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
    Ainsworth RK; Kollias J; Le Blanc A; De Silva P
    Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
    Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
    Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection.
    Kim GR; Choi JS; Han BK; Lee JE; Nam SJ; Ko EY; Ko ES; Lee SK
    Radiology; 2018 Jul; 288(1):55-63. PubMed ID: 29558291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
    Aslani N; Swanson T; Kennecke H; Woods R; Davis N
    Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Achieving breast cancer surgery in a single setting with intraoperative frozen section analysis of the sentinel lymph node.
    Lu Q; Tan EY; Ho B; Teo C; Seah MD; Chen JJ; Chan PM
    Clin Breast Cancer; 2013 Apr; 13(2):140-5. PubMed ID: 23218472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer.
    Fujii T; Yajima R; Tatsuki H; Suto T; Morita H; Tsutsumi S; Kuwano H
    Anticancer Res; 2015 Jun; 35(6):3581-4. PubMed ID: 26026130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Axillary sentinel node biopsy after neoadjuvant chemotherapy.
    Ozmen V; Unal ES; Muslumanoglu ME; Igci A; Canbay E; Ozcinar B; Mudun A; Tunaci M; Tuzlali S; Kecer M
    Eur J Surg Oncol; 2010 Jan; 36(1):23-9. PubMed ID: 19931375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Causes of false-negative sentinel node biopsy in patients with breast cancer.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    Br J Surg; 2013 May; 100(6):775-83. PubMed ID: 23436699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes.
    Hung WK; Chan MC; Mak KL; Chong SF; Lau Y; Ho CM; Yip AW
    ANZ J Surg; 2005; 75(1-2):27-31. PubMed ID: 15740512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
    Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
    Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection].
    Sato K; Hiraide H; Mochizuki H
    Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):445-8. PubMed ID: 11436505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.